Dose distribution of 125Ⅰ seed sources in brachytherapy prostate cancer model
10.3760/cma.j.issn.0254-5098.2011.04.030
- VernacularTitle:125Ⅰ粒子源近距离治疗前列腺癌模型的剂量学研究
- Author:
Rui MA
;
Shuyu YUAN
;
Linghai KONG
;
Liangan ZHANG
- Publication Type:Journal Article
- Keywords:
Brachytherapy;
TLDs;
Prostate cancer;
Iodine-125 seed source DO1:10.3760/cma.j.issn.0254-5098.2011.04.030
- From:
Chinese Journal of Radiological Medicine and Protection
2011;31(4):485-488
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the dose distribution of the radioactive 125Ⅰ seeds sources in the treatment of prostate cancer and also to explore the more effective method for improving treatment planning system (TPS).Methods Choose the designated TPS and use TLDs dosimeter based on a prostate cancer model.Finally stimulated measurement was focused on dose distribution in prostate cancer.The number of 125Ⅰ seed sources implanted was 89, each with 1.37 × 107 ( ± 5% ) Bq.Results Maximum dose of every layer ranged from 151 to 241 Gy, by 4.1% to 66.0% higher than the prescribed dose (145 Gy).The Minimum dose of every layer ranged from 101 to 128 Gy, by 12% to 30% higher than the prescribed dose.The maximum dose of normal tissue at 10 mm from the edge of model ranged from 46 to 91 Gy.The deviation was 44% -63% compared with the prescribed dose.Conclusions The designated TPS shows that it could be used as a practical guide for treatment of prostate cancer with the radioactive 125Ⅰ seed sources.The research methods offered by the study can provide evaluation of the TPS.
